• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution.血管内药物释放动力学决定了动脉药物的沉积、滞留和分布。
J Control Release. 2007 Nov 6;123(2):100-8. doi: 10.1016/j.jconrel.2007.06.025. Epub 2007 Jul 5.
2
Thrombus causes fluctuations in arterial drug delivery from intravascular stents.血栓会导致血管内支架的动脉药物输送出现波动。
J Control Release. 2008 Nov 12;131(3):173-80. doi: 10.1016/j.jconrel.2008.07.027. Epub 2008 Jul 25.
3
Stent elution rate determines drug deposition and receptor-mediated effects.支架洗脱率决定药物沉积和受体介导的作用。
J Control Release. 2012 Aug 10;161(3):918-26. doi: 10.1016/j.jconrel.2012.05.039. Epub 2012 May 26.
4
Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.通过阳离子电沉积涂层技术制备纳米颗粒洗脱支架:经生物可吸收聚合物纳米颗粒洗脱支架在猪冠状动脉中实现高效纳米药物递送
JACC Cardiovasc Interv. 2009 Apr;2(4):277-83. doi: 10.1016/j.jcin.2008.08.023.
5
Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.新兴技术:无聚合物磷脂包裹的西罗莫司纳米载体,用于从支架加球囊或单独球囊导管中控制药物释放。
EuroIntervention. 2013 May 20;9(1):148-56. doi: 10.4244/EIJV9I1A21.
6
Novel Sirolimus-Coated Balloon Catheter: In Vivo Evaluation in a Porcine Coronary Model.新型西罗莫司涂层球囊导管:在猪冠状动脉模型中的体内评估。
Circ Cardiovasc Interv. 2016 Apr;9(4):e003543. doi: 10.1161/CIRCINTERVENTIONS.115.003543.
7
A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices: An Experimental Study Utilizing Porcine Model of In-Stent Restenosis.核磁共振光谱法作为评估支架-聚合物基质中聚左旋乳酸体内生物降解动力学的方法:一项利用猪支架内再狭窄模型的实验研究。
J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):93-9. doi: 10.1177/1074248415583091. Epub 2015 May 5.
8
Tissue sirolimus levels of distal vessel, stented myocardium, and distal myocardium.远端血管、置入支架心肌和远端心肌的组织西罗莫司水平。
JACC Cardiovasc Interv. 2008 Oct;1(5):595; author reply 595. doi: 10.1016/j.jcin.2008.08.005.
9
In vitro study of sirolimus release from a drug-eluting stent: Comparison of the release profiles obtained using different test setups.西罗莫司从药物洗脱支架释放的体外研究:使用不同测试设置获得的释放曲线比较。
Eur J Pharm Biopharm. 2015 Jun;93:328-38. doi: 10.1016/j.ejpb.2015.04.016. Epub 2015 May 1.
10
Paclitaxel-induced arterial wall toxicity and inflammation: tissue uptake in various dose densities in a minipig model.紫杉醇诱导的动脉壁毒性和炎症:小型猪模型中不同剂量密度的组织摄取。
J Vasc Interv Radiol. 2010 Aug;21(8):1262-70. doi: 10.1016/j.jvir.2010.02.020.

引用本文的文献

1
Endovascular Drug Delivery.血管内药物递送
Life (Basel). 2024 Mar 28;14(4):451. doi: 10.3390/life14040451.
2
Hemodynamic Impact of Stenting on Carotid Bifurcation: A Potential Role of the Stented Segment and External Carotid Artery.支架置入对颈动脉分叉处血流动力学的影响:支架段和颈外动脉的潜在作用。
Comput Math Methods Med. 2021 Nov 26;2021:7604532. doi: 10.1155/2021/7604532. eCollection 2021.
3
An Interactive Pipeline for Quantitative Histopathological Analysis of Spatially Defined Drug Effects in Tumors.用于肿瘤中空间定义药物效应定量组织病理学分析的交互式流程
J Pathol Inform. 2021 Sep 16;12:34. doi: 10.4103/jpi.jpi_17_21. eCollection 2021.
4
Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease.将液体疗法精确递送至动脉壁以治疗外周动脉疾病。
Sci Rep. 2021 Sep 21;11(1):18676. doi: 10.1038/s41598-021-98063-z.
5
The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy.生物活性聚合物在干预和组织工程中的应用:心血管治疗的新前沿
Polymers (Basel). 2021 Jan 30;13(3):446. doi: 10.3390/polym13030446.
6
Drug-Eluting Stents and Balloons-Materials, Structure Designs, and Coating Techniques: A Review.药物洗脱支架和球囊-材料、结构设计和涂层技术:综述。
Molecules. 2020 Oct 11;25(20):4624. doi: 10.3390/molecules25204624.
7
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study.超亲水性雷帕霉素涂覆微小结晶型支架与雷帕霉素洗脱聚合物可降解支架的新生内膜增生:DESSOLVE III OCT 研究 6 个月和 24 个月结果。
EuroIntervention. 2021 Feb 19;16(14):1187-1194. doi: 10.4244/EIJ-D-18-01201.
8
Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering.用于血管介入和组织工程的生物活性分子的靶向递送
Front Pharmacol. 2018 Nov 21;9:1329. doi: 10.3389/fphar.2018.01329. eCollection 2018.
9
Cardiovascular stents: overview, evolution, and next generation.心血管支架:概述、演进及下一代产品
Prog Biomater. 2018 Sep;7(3):175-205. doi: 10.1007/s40204-018-0097-y. Epub 2018 Sep 10.
10
Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings.定义支架载药释放后药物和靶蛋白的分布:耐用涂层与可展开涂层。
J Control Release. 2018 Mar 28;274:102-108. doi: 10.1016/j.jconrel.2018.02.007. Epub 2018 Feb 5.

本文引用的文献

1
Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.用于局部递送紫杉醇以治疗再狭窄的聚(乙烯醇)接枝聚(丙交酯 - 乙交酯)纳米颗粒
J Control Release. 2007 May 14;119(1):41-51. doi: 10.1016/j.jconrel.2007.01.009. Epub 2007 Jan 26.
2
Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.非聚合物紫杉醇洗脱支架植入术后定量血管造影和容积血管内超声分析的两年随访:来自ASPECT研究的晚期“追赶”现象
J Am Coll Cardiol. 2006 Dec 19;48(12):2432-9. doi: 10.1016/j.jacc.2006.08.033. Epub 2006 Nov 28.
3
Polymers, drug release, and drug-eluting stents.聚合物、药物释放与药物洗脱支架
J Interv Cardiol. 2006 Dec;19(6):500-6. doi: 10.1111/j.1540-8183.2006.00198.x.
4
Release of anti-restenosis drugs from poly(ethylene oxide)-poly(DL-lactic-co-glycolic acid) nanoparticles.抗再狭窄药物从聚环氧乙烷-聚(DL-乳酸-乙醇酸)纳米颗粒中的释放。
J Control Release. 2006 Sep 12;114(3):317-24. doi: 10.1016/j.jconrel.2006.05.021. Epub 2006 Jun 2.
5
Mechanisms of controlled drug release from drug-eluting stents.药物洗脱支架的药物控释机制。
Adv Drug Deliv Rev. 2006 Jun 3;58(3):387-401. doi: 10.1016/j.addr.2006.01.016. Epub 2006 Mar 6.
6
A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus.一种新型药物洗脱支架,喷涂有多层胶原蛋白和西罗莫司。
J Control Release. 2005 Nov 2;108(1):178-89. doi: 10.1016/j.jconrel.2005.07.022. Epub 2005 Sep 12.
7
Drug delivery by angiographic contrast media: inhibition of restenosis.通过血管造影剂进行药物递送:抑制再狭窄。
Acad Radiol. 2005 May;12 Suppl 1:S14-7. doi: 10.1016/j.acra.2005.02.017.
8
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).使用新型紫杉醇洗脱支架平台研究可变剂量和释放动力学对新生内膜增生的影响:紫杉醇支架内控制洗脱研究(PISCES)
J Am Coll Cardiol. 2005 Jul 19;46(2):253-60. doi: 10.1016/j.jacc.2005.03.069.
9
Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).紫杉醇洗脱支架治疗初发冠状动脉狭窄的两年以上随访(TAXUS I)
Am J Cardiol. 2005 Jul 1;96(1):79-82. doi: 10.1016/j.amjcard.2005.03.030.
10
Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents.支架位置、血流及药物沉积:对单药洗脱支架和重叠药物洗脱支架的影响
Circulation. 2005 Jun 7;111(22):2958-65. doi: 10.1161/CIRCULATIONAHA.104.512475. Epub 2005 May 31.

血管内药物释放动力学决定了动脉药物的沉积、滞留和分布。

Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution.

作者信息

Balakrishnan Brinda, Dooley John F, Kopia Gregory, Edelman Elazer R

机构信息

Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

J Control Release. 2007 Nov 6;123(2):100-8. doi: 10.1016/j.jconrel.2007.06.025. Epub 2007 Jul 5.

DOI:10.1016/j.jconrel.2007.06.025
PMID:17868948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2702153/
Abstract

Millions of patients worldwide have received drug-eluting stents to reduce their risk for in-stent restenosis. The efficacy and toxicity of these local therapeutics depend upon arterial drug deposition, distribution, and retention. To examine how administered dose and drug release kinetics control arterial drug uptake, a model was created using principles of computational fluid dynamics and transient drug diffusion-convection. The modeling predictions for drug elution were validated using empiric data from stented porcine coronary arteries. Inefficient, minimal arterial drug deposition was predicted when a bolus of drug was released and depleted within seconds. Month-long stent-based drug release efficiently delivered nearly continuous drug levels, but the slow rate of drug presentation limited arterial drug uptake. Uptake was only maximized when the rates of drug release and absorption matched, which occurred for hour-long drug release. Of the two possible means for increasing the amount of drug on the stent, modulation of drug concentration potently impacts the magnitude of arterial drug deposition, while changes in coating drug mass affect duration of release. We demonstrate the importance of drug release kinetics and administered drug dose in governing arterial drug uptake and suggest novel drug delivery strategies for controlling spatio-temporal arterial drug distribution.

摘要

全球数百万患者接受了药物洗脱支架以降低支架内再狭窄风险。这些局部治疗药物的疗效和毒性取决于动脉内药物的沉积、分布和滞留情况。为了研究给药剂量和药物释放动力学如何控制动脉药物摄取,利用计算流体动力学原理和瞬态药物扩散 - 对流建立了一个模型。使用来自置入支架的猪冠状动脉的经验数据对药物洗脱的建模预测进行了验证。当一团药物在数秒内释放并耗尽时,预测动脉药物沉积效率低下且极少。基于支架的长达一个月的药物释放有效地提供了几乎持续的药物水平,但药物呈现速率缓慢限制了动脉药物摄取。只有当药物释放速率和吸收速率匹配时摄取才达到最大化,这发生在长达一小时的药物释放过程中。在增加支架上药物量的两种可能方法中,调节药物浓度对动脉药物沉积量有显著影响,而包衣药物质量的变化影响释放持续时间。我们证明了药物释放动力学和给药剂量在控制动脉药物摄取方面的重要性,并提出了用于控制动脉药物时空分布的新型给药策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/ce8d677258ef/nihms33597f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/96e90c3ff3f2/nihms33597f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/fbd90a19cb3c/nihms33597f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/e9b09b44e1e7/nihms33597f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/c9501578b142/nihms33597f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/f868072bd284/nihms33597f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/f06eb0348e2a/nihms33597f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/23bc410b1f6e/nihms33597f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/ce8d677258ef/nihms33597f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/96e90c3ff3f2/nihms33597f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/fbd90a19cb3c/nihms33597f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/e9b09b44e1e7/nihms33597f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/c9501578b142/nihms33597f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/f868072bd284/nihms33597f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/f06eb0348e2a/nihms33597f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/23bc410b1f6e/nihms33597f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130b/2702153/ce8d677258ef/nihms33597f8.jpg